Nordic BioVentures AMBA — Credit Rating and Financial Key Figures
CVR number: 43852116
Blegdamsvej 6, 2200 København N
josephine@nordicbioventures.com
tel: 22627767
www.nordicbioventures.com
Income statement (kDKK)
2023 | |
---|---|
Fiscal period length | 12 |
Net sales | |
Gross profit | 3 281.45 |
Employee benefit expenses | -1 398.91 |
EBIT | 1 882.54 |
Other financial income | 10.07 |
Pre-tax profit | 1 892.61 |
Income taxes | - 422.00 |
Net earnings | 1 470.61 |
Assets (kDKK)
2023 | |
---|---|
Intangible assets total | |
Tangible assets total | |
Participating interests | 670.00 |
Investments total | 670.00 |
Long term receivables total | |
Inventories total | |
Current trade debtors | 32.39 |
Current other receivables | 881.01 |
Short term receivables total | 913.40 |
Cash and bank deposits | 518.30 |
Cash and cash equivalents | 518.30 |
Balance sheet total (assets) | 2 101.70 |
Equity and liabilities (kDKK)
2023 | |
---|---|
Profit of the financial year | 1 470.61 |
Shareholders equity total | 1 470.61 |
Non-current liabilities total | |
Current trade creditors | 19.64 |
Current owed to participating | 0.40 |
Short-term deferred tax liabilities | 422.00 |
Other non-interest bearing current liabilities | 189.05 |
Current liabilities total | 631.09 |
Balance sheet total (liabilities) | 2 101.70 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.